In summary, the current study elucidated that YBX1 can promote ESCC progression by stabilizing SMOX mRNA and consequently activating the mTOCR1 signaling pathway in an NSUN2‐mediated m5C modification‐dependent manner. Here, NSUN2 is linked to esophageal squamous cell carcinoma.